GENE ONLINE|News &
Opinion
Blog

2022-04-19| COVID-19

KKR-led Group Attempts $14.8 Billion Takeover of Australia’s Ramsay Health Care

by Joy Lin
Share To

A group led by private equity firm KKR & Co has pushed forward with a $14.8 billion bid for Ramsay Health Care. Their takeover attempt sent the Australian company’s shares up by as much as 30%. 

The consortium has offered to buy Ramsay’s shares for A$88 per share in cash, a 37% premium to their last close. If it goes through, it would be the biggest private-equity-backed buyout of an Australian company. 

Ramsay has released a statement saying that preliminary talks were underway. 

Founded in 1964 by businessman Paul Ramsay, Ramsay has since established a global network of healthcare facilities spanning Australia, the UK, Europe, and Asia. 

 

Supporters of the Deal 

 

The takeover has support from a key shareholder of Ramsay. The Paul Ramsay Foundation (PRF), which is the company’s biggest shareholder with a 18.8% stake, has released a statement expressing support. 

“Assessment of any conditional indicative offer is up to the board of Ramsay Health Care. However, should an offer materialise along the lines canvassed in Ramsay Health Care’s ASX Announcement, PRF would support such an offer being put to shareholders,” it said.

The consortium of investors also includes HESTA, Australia’s industry fund for healthcare workers, and Abu Dhabi Investment Authority, the sovereign fund for the United Arab Emirates. 

 

COVID-19 and Other M&As

 

The COVID-19 pandemic has impacted healthcare services and providers such as Ramsay, halting non-urgent surgeries and increasing staff shortages due to isolation regulations.

The recent years have also seen a number of acquisitions involving Australian companies. 

Last year, Australian biopharma CSL revealed a $11.7 billion offer for Swiss drugmaker Vifor Pharma to expand its existing pipeline and diversify from its blood plasma business. 

Meanwhile, Ramsay’s rival Healthscope delisted from the ASX following a $4.1 billion takeover by Brookfield Asset Management in 201.

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
R&D
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Taiwanese Hospitals Make Strong Showing in “World’s Best Hospitals” Ranking
2024-03-12
The Gates Foundation Boosts Global Health Innovations with Record $8.6 Billion Budget
2024-01-18
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top